http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2006257020-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5859836cd5b65a17aa0963b145287c90
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M5-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-08
filingDate 2005-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c851854c1d47f0fb85cf42592eb77663
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_826a89ed664498a0b3d105843c1c5011
publicationDate 2006-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2006257020-A
titleOfInvention Stable high concentration edaravone injection
abstract 【Task】 To provide a stable high concentration edaravone injection. [Solution] Edaravone concentration as an active ingredient is in the range of 1.5 w / w% to 3.5 w / w%, contains ethanol as a solubilizer, and is further selected from sodium bisulfite and sodium pyrosulfite as stabilizers A high-concentration edaravone injection containing the above is provided.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010162344-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9006280-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009155315-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009143902-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010130577-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-101933899-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110090225-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113125608-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010528000-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113125608-B
priorityDate 2005-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H07121861-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02092082-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448616730
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396647
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4021
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454515022
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419497836
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23665763

Total number of triples: 36.